Heterocyclic compounds as pad inhibitors

US12357639B2 · kind B2 · utility

Assignee

• JUBILANT EPIPAD LLC · US

Inventors

• Gurulingappa Hallur · Kanchinakote, IN
• Athisayamani Jeyaraj Duraiswamy · Singapore, SG
• Buchi Reddy Purra · Kanchinakote, IN
• N.V.S.K. RAO · Kanchinakote, IN
• Sridharan Rajagopal · Bengaluru, IN

Key dates

• Filing date: Nov 17, 2023
• Grant date: Jul 15, 2025
• Expiry date: Nov 17, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Heterocyclic compounds of Formula (I) are described herein along with their stereoisomers and pharmaceutically acceptable salts thereof. The compounds described herein, their stereoisomers, and pharmaceutically acceptable salts thereof are PAD4 inhibitors and may be useful in the treatment of various disorders, for example rheumatoid arthritis.